Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameJD Health
Stock Code06618
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities零售藥房業務及在線醫療健康服務。通過自營、線上平台及全渠道佈局銷售醫藥和健康產品,並提供在線問診、處方續簽、慢性病管理、家庭醫生及消費醫療健康服務。亦為醫院、藥企等提供數字化解決方案。
Listing Date2020-12-08
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中華人民共和國北京市大興區亦莊經濟技術開發區科創十一街18號院C座8樓(郵編:101111)
Business Address (Hong Kong)香港銅鑼灣希慎道33號利園一期19樓1901室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websiteir.jdhealth.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 70.58 / shares
Offer Price RangeFinal offer price only, no range
Lot Size50 shares
Entry ThresholdHK$ 3,529
Par ValueTo be extracted
Offer Period2020-11-26 to 2020-12-01
Global Offering Shares381,900,000 shares
HK Public Offer Shares (Initial)19,095,000 shares (5.0%)
Public Offer Lots (Initial)381,900lots (Pool A190,950lots,Pool B190,950lots)
International Placing Shares (Initial)362,805,000 shares (95.0%)
Offer Ratio~5.0%
Total Shares Post-IPO3,127,082,111 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share38.8%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 26,954,502,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 50 HK$ 3,529
2 lots 100 HK$ 7,058
3 lots 150 HK$ 10,587
4 lots 200 HK$ 14,116
5 lots 250 HK$ 17,645
6 lots 300 HK$ 21,174
7 lots 350 HK$ 24,703
8 lots 400 HK$ 28,232
9 lots 450 HK$ 31,761
10 lots 500 HK$ 35,290
12 lots 600 HK$ 42,348
14 lots 700 HK$ 49,406
16 lots 800 HK$ 56,464
18 lots 900 HK$ 63,522
20 lots 1,000 HK$ 70,580
30 lots 1,500 HK$ 105,870
40 lots 2,000 HK$ 141,160
50 lots 2,500 HK$ 176,450
60 lots 3,000 HK$ 211,740
70 lots 3,500 HK$ 247,030
80 lots 4,000 HK$ 282,320
90 lots 4,500 HK$ 317,610
100 lots 5,000 HK$ 352,900
120 lots 6,000 HK$ 423,480
140 lots 7,000 HK$ 494,060
160 lots 8,000 HK$ 564,640
180 lots 9,000 HK$ 635,220
200 lots 10,000 HK$ 705,800
400 lots 20,000 HK$ 1,411,600
600 lots 30,000 HK$ 2,117,400
800 lots 40,000 HK$ 2,823,200
1,000 lots 50,000 HK$ 3,529,000
1,200 lots 60,000 HK$ 4,234,800
1,400 lots 70,000 HK$ 4,940,600
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,600 lots 80,000 HK$ 5,646,400
1,800 lots 90,000 HK$ 6,352,200
2,000 lots 100,000 HK$ 7,058,000
4,000 lots 200,000 HK$ 14,116,000
6,000 lots 300,000 HK$ 21,174,000
8,000 lots 400,000 HK$ 28,232,000
10,000 lots 500,000 HK$ 35,290,000
12,000 lots 600,000 HK$ 42,348,000
14,000 lots 700,000 HK$ 49,406,000
16,000 lots 800,000 HK$ 56,464,000
18,000 lots 900,000 HK$ 63,522,000
20,000 lots 1,000,000 HK$ 70,580,000
40,000 lots 2,000,000 HK$ 141,160,000
60,000 lots 3,000,000 HK$ 211,740,000
90,000 lots 4,500,000 HK$ 317,610,000
120,000 lots 6,000,000 HK$ 423,480,000
150,000 lots 7,500,000 HK$ 529,350,000
190,950 lots 9,547,500 HK$ 673,862,550

Stock Connect Inclusion Analysis

Avg Daily HK Mkt Cap HK$ 136.77B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)HK$ 220,709,455,394
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status虧損人民幣971.8百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201720182019
Revenue 5,553,1288,169,05710,842,140
Cost of sales -4,172,630-6,190,099-8,029,868
Gross profit 1,380,4981,978,9582,812,272
Other income and gains, net -2213,562565
Selling and distribution expenses -257,979-391,822-746,014
Administrative expenses -107,417-133,855-124,922
Net finance costs -82-150-35,502
Profit before tax 255,979306,232-834,700
Income tax expense -77,445-91,305-137,105
Profit for the year 178,534214,927-971,805
Profit attributable to owners 178,534214,927-971,805
Balance Sheet
Item 201720182019
Cash and cash equivalents 7,40116,2134,965,272
Trade and bills receivables 3,09120,03221,552
Inventories 884,0471,115,2951,278,339
Total current assets 901,1451,166,3378,624,043
Total assets 911,3631,182,1478,676,677
Total current liabilities 247,145430,5151,544,876
Total liabilities 248,739432,9269,135,708
Total equity 662,624749,221-459,031
Equity attributable to owners 662,624749,221-459,031
Cash Flow Statement
Item 2017201820192020-06
Net cash from operating activities 36,116187,226409,470
Net cash from investing activities -8,623-13,689-1,448,623
Net cash from financing activities -33,299-2,9246,509,119
Net increase in cash -5,806170,6135,469,966
Purchase of PP&E -842-2,013-5,186-6,640
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 110.0
First Day OpenHK$ 94.5
First Day Change55.85%
First Day Volume156500000.0
First Day Turnover16039300000.0
Use of Proceeds
1、約40%募集資金凈額(或約10,583百萬港元)預計在未來36至60個月將用于業務擴張; 2、約30%募集資金凈額(或約7,937百萬港元)預計在未來24至36個月將用于研發; 3、約20%募集資金凈額(或約5,291百萬港元)預計將用于潛在投資及收購或戰略聯盟; 4、約10%募集資金凈額(或約2,646百萬港元)預計將用于營運資金及一般公司用途。

Underwriting Syndicate

Joint Sponsors (3)
Merrill Lynch (Asia Pacific) Limited CE AAC198 海通国际资本有限公司 CE ADQ859 UBS Securities Hong Kong Limited CE BIN466
Overall Coordinators (9)
Merrill Lynch (Asia Pacific) Limited CE AAC198 海通国际证券有限公司 CE AAF806 UBS Securities Hong Kong Limited CE BIN466 China Renaissance Securities (Hong Kong) Limited CE AZX839 GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 CLSA LIMITED CE AAB893 Jefferies Hong Kong Limited CE ATS546 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 BOCI ASIA LIMITED CE AET863
Joint Bookrunners (17)
Merrill Lynch (Asia Pacific) Limited CE AAC198 海通国际证券有限公司 CE AAF806 UBS Securities Hong Kong Limited CE BIN466 China Renaissance Securities (Hong Kong) Limited CE AZX839 GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 CLSA LIMITED CE AAB893 Jefferies Hong Kong Limited CE ATS546 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 BOCI ASIA LIMITED CE AET863 建银国际金融有限公司 CE AJO225 交银国际证券有限公司 CE APJ121 农银国际证券有限公司 CE ACX411 招银国际融资有限公司 CE AVM940 国泰君安证券(香港)有限公司 CE ABY236 星展亚洲融资有限公司 CE AAE430 MIZUHO SECURITIES ASIA LIMITED CE AEZ953 富途证券国际(香港)有限公司 CE AZT137
Joint Lead Managers (17)
Merrill Lynch (Asia Pacific) Limited CE AAC198 海通国际证券有限公司 CE AAF806 UBS Securities Hong Kong Limited CE BIN466 China Renaissance Securities (Hong Kong) Limited CE AZX839 GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 CLSA LIMITED CE AAB893 Jefferies Hong Kong Limited CE ATS546 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 BOCI ASIA LIMITED CE AET863 建银国际金融有限公司 CE AJO225 交银国际证券有限公司 CE APJ121 农银国际证券有限公司 CE ACX411 招银国际融资有限公司 CE AVM940 国泰君安证券(香港)有限公司 CE ABY236 星展亚洲融资有限公司 CE AAE430 MIZUHO SECURITIES ASIA LIMITED CE AEZ953 富途证券国际(香港)有限公司 CE AZT137

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 BlackRock Funds 1,938,140,916 HKD — 7.19% — 6 months 2021-06-08
2 GIC Private Limited 2,713,398,694 HKD — 10.07% — 6 months 2021-06-08
3 Hillhouse Funds 1,170,498,720 HKD — 4.34% — 6 months 2021-06-08
4 Internet Fund IIIA Pte Ltd 2,325,769,805 HKD — 8.63% — 6 months 2021-06-08
5 Lake Bleu Prime Healthcare Master Fund Limited 775,254,249 HKD — 2.88% — 6 months 2021-06-08
6 中国国有企业结构调整基金股份有限公司 1,544,435,089 HKD — 5.73% — 6 months 2021-06-08

Directors & Management

PositionChinese nameEnglish Name
Chairman劉強東—
Company Secretary趙明璟—
No director data available.

Major Shareholders

Major Shareholders & HoldingsJD Jiankang及JD.com(通過JD Jiankang)於緊隨全球發售完成後持有2,149,253,732股股份,佔已發行股本約68.73%
About this page

This page shows JD Health (06618) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect